Pharma/Medical Device Companies Projecting Expansion for 2022

Results of a Q1 2022 report from PMMI show that the pharmaceutical/medical device industry is expecting the most growth, followed by other, personal care, food, and beverage.

Q1 2022 Quarterly Business Indictaor Qbi 1

PMMI's Quarterly Business Indicator, providing benchmarking data on new orders, general business conditions, and OEM versus end user performance, is your guide to past performance metrics and CPG investment activity. According to the newly released Q1 2022 report, consumer packaged goods (CPG) companies are generally optimistic about scheduled projects.

  • Results show that the pharmaceutical/medical device industry is expecting the most growth, followed by other, personal care, food, and beverage.
  • Meanwhile, all responding consumer packaged goods (CPG) companies are projecting expansion in scheduled projects in Q2 2022.
  • Manufacturers in the pharmaceutical/medical device segment are very optimistic that scheduled projects will remain on track; 10.8 points over the total market.
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report